Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.2221
Delayed Data
As of Feb 22
 0.00008 / +0.04%
Today’s Change
0.03
Today|||52-Week Range
0.35
-17.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues34.5M31.2M17.5M8.4M
 
 
 
 
 
Depreciation And Amortization232.0K0.000.000.00
 
 
 
Operating ExpensesGross Income34.3M------
 
 
General Expenses11.3M2.4M2.2M1.7M
 
 
 
 
 
Research And Development2.7M0.00----
 
 
Total Operating Expenses11.6M2.4M2.2M1.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income22.9M28.8M15.3M6.7M
 
 
 
 
 
Extraordinary Charge-4.8M---4.5M-54.0K
 
 
 
 
Interest Expense On Debt2.1M0.000.000.00
 
 
Other Expenses1.9M61.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income18.1M28.9M10.8M6.6M
 
 
 
 
 
Income Taxes-28.0K-56.0K-10.8M-7.8M
 
 
 
 
 
Net Income18.2M28.8M21.6M-1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.8M44.1M44.2M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted51.0M44.2M44.2M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.38$0.65$0.49-$0.03
 
 
 
 
 
EPS Diluted$0.36$0.65$0.49-$0.03